All diseases

Disease Atlas / Disease detail

Histoplasmosis

An atlas of environmental spore inhalation, pulmonary and disseminated infection, antigen testing, and severity-based antifungal care.

histoplasmosis · Histoplasma infection

MONDO:0018312Public QA completeSource-bound · 4

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · bf58fcd2037d

Disease class
Histoplasmosis is a fungal infection.
Core mechanism
Inhaled environmental Histoplasma spores cause infection.
Genes or cause
Soil contaminated by bird or bat droppings increases risk.
Typical features
Fever, cough, and fatigue can occur.
Variability
Many acute pulmonary infections resolve spontaneously.
Diagnosis
Immunocompromised people have higher dissemination risk.
Management
Urine and serum antigen tests aid diagnosis.
Treatment and research
Culture, microscopy, and antibody tests provide contextual support.
Reading evidence
Test sensitivity varies by disease form and immunity.
Key caution
Severe, chronic, and disseminated disease requires antifungals.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a glance

Histoplasmosis is a fungal infection.

Fever, cough, and fatigue can occur.

How the disease works

Inhaled environmental Histoplasma spores cause infection.

Soil contaminated by bird or bat droppings increases risk.

Why experiences vary

Many acute pulmonary infections resolve spontaneously.

Diagnosis and management

Immunocompromised people have higher dissemination risk.

Treatment status

Urine and serum antigen tests aid diagnosis.

Culture, microscopy, and antibody tests provide contextual support.

Reading clinical trials

Drug levels, interactions, and relapse are monitored.

Topics for a clinical visit

Immunity, disease form, and CNS involvement require review.

Medical notice

This material is for disease education and is not a personal diagnosis or treatment instruction.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.